↓ Skip to main content

Neoadjuvant 5-FU or Capecitabine Plus Radiation With or Without Oxaliplatin in Rectal Cancer Patients: A Phase III Randomized Clinical Trial

Overview of attention for article published in JNCI: Journal of the National Cancer Institute, September 2015
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (95th percentile)
  • High Attention Score compared to outputs of the same age and source (83rd percentile)

Mentioned by

news
1 news outlet
twitter
7 X users
facebook
1 Facebook page
guideline
8 clinical guideline sources

Readers on

mendeley
213 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Article details
Title
Neoadjuvant 5-FU or Capecitabine Plus Radiation With or Without Oxaliplatin in Rectal Cancer Patients: A Phase III Randomized Clinical Trial
Published in
JNCI: Journal of the National Cancer Institute, September 2015
DOI 10.1093/jnci/djv248
Pubmed ID
Authors

Login to access the Attention Digest and the Sentiment Analysis related to this output.

Timeline Attention over time Attention Score history
Login to access the full charts related to this output.
Activity
Login to access the full charts related to this output.
X Demographics

X Demographics

The data shown below were collected from the profiles of 7 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley demographics

Mendeley demographics

The data shown below were compiled from readership statistics for 213 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Login to view Mendeley reader trends over time.

Geographical breakdown

Geographical breakdown
Country Count As %
Unknown 213 100%

Demographic breakdown

Readers by professional status
Readers by professional status Count As %
Student > Ph. D. Student 25 12%
Researcher 25 12%
Student > Postgraduate 21 10%
Student > Master 20 9%
Student > Doctoral Student 16 8%
Other 46 22%
Unknown 60 28%
Readers by discipline
Readers by discipline Count As %
Medicine and Dentistry 104 49%
Nursing and Health Professions 9 4%
Biochemistry, Genetics and Molecular Biology 8 4%
Agricultural and Biological Sciences 4 2%
Pharmacology, Toxicology and Pharmaceutical Science 3 1%
Other 15 7%
Unknown 70 33%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 37. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 04 November 2025.
All research outputs
#1,400,852
of 34,526,284 outputs
Outputs from JNCI: Journal of the National Cancer Institute
#925
of 9,912 outputs
Outputs of similar age
#14,768
of 305,515 outputs
Outputs of similar age from JNCI: Journal of the National Cancer Institute
#18
of 112 outputs
Altmetric has tracked 34,526,284 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 95th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 9,912 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 21.2. This one has done particularly well, scoring higher than 90% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 305,515 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 95% of its contemporaries.
We're also able to compare this research output to 112 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 83% of its contemporaries.